Key result
Between 10 to 30% of patients with coronary disease still suffer from symptoms of angina pectoris, which impacts survival rates, functional status, quality of life, and health-related costs.
Angina pectoris remains a significant burden in contemporary clinical practice, affecting 10-30% of patients with coronary disease and impacting survival, quality of life, and healthcare costs.
Persistent angina burden signals unmet need in CAD management; leaves open targeted therapies and prospective trials.
Between 10 to 30% of patients with coronary disease still suffer from symptoms of angina pectoris in contemporary clinical practice. This article summarizes analytic tools for measuring angina, as well as, its prevalence based on community based surveys, registries and in randomized controlled trials. Additionally, the impact of angina symptoms on patients' survival rates, functional status, quality of life and health-related costs is reviewed. The effectiveness of treatment, revascularization and medical therapies, on reducing angina symptoms is also reviewed.
No takes yet. Share an insight, caveat, or question.
Eric D. Peterson (2007) conducted a review in Angina pectoris in coronary disease. Between 10 to 30% of patients with coronary disease still suffer from symptoms of angina pectoris, which impacts survival rates, functional status, quality of life, and health-related costs.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: